Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma

Clinical trial NCT05173610 · UNKNOWN

Trial details

NCT number: NCT05173610
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastasis Hepatocellular Carcinoma

Start date: 2021-09-28
Primary completion: 2022-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.